Filana Therapeutics, Inc. (FLNA)Healthcare | Biotechnology | Austin, United States | NasdaqCM
0.93 USD
+0.01
(0.650%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 0.93 0.00 (-0.001%) ⇩ (Aug. 28, 2026, 7:50 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:48 a.m. EDT
The investment case for Filana Therapeutics is currently overwhelmed by structural deterioration and extreme distress. The stock has lost over 87% of its value over the last nine years, with the most recent annual performance showing a catastrophic 92.6% decline. This is not a temporary correction; it is a multi-year implosion where the market has priced out the business entirely. Fundamentals confirm the despair: negative equity, massive losses, and a balance sheet that is barely holding on despite a cash pile that seems insufficient for the long road ahead in biotech. The recent name change from Cassava Sciences offers a narrative of rebirth, but the price action tells a different story, trading near its 52-week low with no momentum to speak of. Options markets reflect this fear, with traders buying cheap insurance against further collapse rather than betting on a rally. While the analyst targets suggest a potential 6x recovery, the path to get there requires a miracle in clinical trials or a massive strategic deal, as the current trajectory points firmly toward continued erosion of shareholder value. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.064969 |
| AutoARIMA | 0.153196 |
| AutoETS | 0.153197 |
| MSTL | 0.160271 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 0.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.972 |
| Excess Kurtosis | -0.15 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2012-12-12 |
| Last Dividend Date | 2012-12-12 |
| Market Cap | 44,878,036 |
| Beta | -0.69 |
| Previous Name | Cassava Sciences, Inc. |
| Website | https://www.filanatx.com |
As of Aug. 22, 2026, 2:48 a.m. EDT: Speculators are heavily positioned for downside protection, with significant open interest in out-of-the-money puts expiring in early 2027 (strikes $2.00-$2.50) and deep OTM puts for 2028. Call activity is sparse and concentrated in the money, while implied volatility remains extremely low, indicating a lack of speculative optimism despite the company's recent name change and pipeline updates.
| Date | Dividend | Yield % |
|---|---|---|
| 2012-12-13 | 5.25 | 29.644270 |
| 2010-12-13 | 14.00 | 30.395136 |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5947137 |
| Address1 | 6,801 N. Capital of Texas Highway |
| Address2 | Building 1 |
| All Time High | 184.625 |
| All Time Low | 0.76 |
| Ask | 0.9789 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 212,860 |
| Average Daily Volume3 Month | 326,275 |
| Average Volume | 326,275 |
| Average Volume10Days | 212,860 |
| Beta | -0.686 |
| Bid | 1.02 |
| Bid Size | 1 |
| Book Value | 1.317 |
| City | Austin |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.929 |
| Current Ratio | 2.085 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 0.9313 |
| Day Low | 0.91 |
| Display Name | Filana Therapeutics |
| Earnings Timestamp | 1,785,328,200 |
| Earnings Timestamp End | 1,793,277,000 |
| Earnings Timestamp Start | 1,793,277,000 |
| Ebitda | -12,688,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 2.979 |
| Enterprise Value | -37,802,964 |
| Eps Trailing Twelve Months | -0.87 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,355,356,800 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.0474 |
| Fifty Day Average Change | -0.11839998 |
| Fifty Day Average Change Percent | -0.113041796 |
| Fifty Two Week Change Percent | -59.471367 |
| Fifty Two Week High | 4.98 |
| Fifty Two Week High Change | -4.051 |
| Fifty Two Week High Change Percent | -0.81345385 |
| Fifty Two Week Low | 0.85 |
| Fifty Two Week Low Change | 0.078999996 |
| Fifty Two Week Low Change Percent | 0.09294117 |
| Fifty Two Week Range | 0.85 - 4.98 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 963,581,400,000 |
| Float Shares | 47,317,584 |
| Free Cashflow | 3,977,375 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 17 |
| Fullday Change | 0.00600004 |
| Fullday Change Percent | 0.650059 |
| Fullday Price | 0.928 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -15,655,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.020499999 |
| Held Percent Institutions | 0.26723 |
| Implied Shares Outstanding | 48,307,896 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ir Website | http://investor.paintrials.com/stockquote.cfm |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Dividend Date | 1,355,356,800 |
| Last Dividend Value | 5.25 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,494,374,400 |
| Last Split Factor | 1:7 |
| Long Business Summary | Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas. |
| Long Name | Filana Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 44,878,036 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_107567 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-29 |
| Net Income To Common | -42,280,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 44,588,188 |
| Number Of Analyst Opinions | 2 |
| Open | 0.9313 |
| Operating Cashflow | -28,702,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.62 |
| Phone | 512 501 2444 |
| Post Market Change | -0.0010000467 |
| Post Market Change Percent | -0.10764766 |
| Post Market Price | 0.928 |
| Post Market Time | 1,787,961,042 |
| Prev Name | Cassava Sciences, Inc. |
| Previous Close | 0.923 |
| Price Hint | 4 |
| Price To Book | 0.70539105 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.059 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.00600004 |
| Regular Market Change Percent | 0.650059 |
| Regular Market Day High | 0.9313 |
| Regular Market Day Low | 0.91 |
| Regular Market Day Range | 0.91 - 0.9313 |
| Regular Market Open | 0.9313 |
| Regular Market Previous Close | 0.923 |
| Regular Market Price | 0.929 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 169,676 |
| Return On Assets | -0.07143 |
| Return On Equity | -0.55785 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 48,307,896 |
| Shares Percent Shares Out | 0.1306 |
| Shares Short | 6,310,680 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 6,238,298 |
| Short Name | Filana Therapeutics, Inc. |
| Short Percent Of Float | 0.13340001 |
| Short Ratio | 18.98 |
| Source Interval | 15 |
| State | TX |
| Symbol | FLNA |
| Target High Price | 8.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 6.5 |
| Target Median Price | 6.5 |
| Total Cash | 82,681,000 |
| Total Cash Per Share | 1.712 |
| Total Debt | 0 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.87 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.7849 |
| Two Hundred Day Average Change | -0.85589993 |
| Two Hundred Day Average Change Percent | -0.47952265 |
| Type Disp | Equity |
| Volume | 169,676 |
| Website | https://www.filanatx.com |
| Zip | 78,731 |